{"id":291,"date":"2021-05-06T16:34:11","date_gmt":"2021-05-06T20:34:11","guid":{"rendered":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/?p=291"},"modified":"2021-05-06T16:34:11","modified_gmt":"2021-05-06T20:34:11","slug":"proposed-temporary-waiver-of-covid-19-vaccine-related-intellectual-property-rights-considerations-and-implications","status":"publish","type":"post","link":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/2021\/05\/06\/proposed-temporary-waiver-of-covid-19-vaccine-related-intellectual-property-rights-considerations-and-implications\/","title":{"rendered":"Proposed Temporary Waiver of COVID-19 Vaccine-Related Intellectual Property Rights: Considerations and Implications"},"content":{"rendered":"<p>The World Trade Organization is considering a proposal, advanced by India and South Africa in October 2020, to waive intellectual property rights related to the development of the vaccines against COVID-19 for the duration of the pandemic. The Biden administration has indicated its support.<\/p>\n<p>To read the full text of this Duane Morris\u00a0<em>Alert<\/em>, please\u00a0<a href=\"https:\/\/www.duanemorris.com\/alerts\/considerations_implications_proposed_temporary_waiver_covid19_vaccine_related_intellectual_0521.html\" target=\"_blank\" rel=\"noopener\">visit the firm website<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The World Trade Organization is considering a proposal, advanced by India and South Africa in October 2020, to waive intellectual property rights related to the development of the vaccines against COVID-19 for the duration of the pandemic. The Biden administration has indicated its support. To read the full text of this Duane Morris\u00a0Alert, please\u00a0visit the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/2021\/05\/06\/proposed-temporary-waiver-of-covid-19-vaccine-related-intellectual-property-rights-considerations-and-implications\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Proposed Temporary Waiver of COVID-19 Vaccine-Related Intellectual Property Rights: Considerations and Implications&#8221;<\/span><\/a><\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[430,429,10,558,157,559,556,557],"ppma_author":[521],"class_list":["post-291","post","type-post","status-publish","format-standard","hentry","category-general","tag-coronavirus","tag-covid-19","tag-intellectual-property","tag-intellectual-property-rights","tag-ipr","tag-vaccine","tag-world-trade-organization","tag-wto"],"authors":[{"term_id":521,"user_id":6,"is_guest":0,"slug":"duanemorris3","display_name":"Duane Morris","avatar_url":"https:\/\/secure.gravatar.com\/avatar\/843ff6e7a8fe5fc92109b47a45f34b6cf0ea499e6e788db23456c838b0ae6747?s=96&d=blank&r=g","0":null,"1":"","2":"","3":"","4":"","5":"","6":"","7":"","8":""}],"_links":{"self":[{"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/posts\/291","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/comments?post=291"}],"version-history":[{"count":0,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/posts\/291\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/media?parent=291"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/categories?post=291"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/tags?post=291"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/ppma_author?post=291"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}